ROCKVILLE, Md.--(BUSINESS WIRE)--Innovative Biosensors, Inc. (IBI), a company developing rapid, ultra-sensitive tests to detect harmful pathogens for both the clinical infectious disease and biodefense markets, today announced that Joe Hernandez, President and Chief Executive Officer, has been invited to present at the Acumen BioFin™ Rodman & Renshaw 9th Annual Global Healthcare Conference on November 5-7 in New York City.
